COMP <GO>
HIMS vs OPCH // NET PROFIT MARGIN
Hims & Hers Health Inc. (NYSE) VS. Option Care Health Inc. (NASDAQ) • 15-METRIC TALLY: HIMS 6
— OPCH 7
▲ NET PROFIT MARGIN LEADER: HIMS
LAST: $25.24 (-8.81%) • MKT CAP: $6.46B
net-margins
5.50%
LAST: $31.69 (-0.44%) • MKT CAP: $4.77B
net-margins
3.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HIMS VS. OPCH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HIMS | OPCH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 73.80% | 19.30% | +54.50 | HIMS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.40% | 11.90% | -3.50 | OPCH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.7x | 15.3x | +22.40 | OPCH | /valuation <GO> |
| Free Cash Flow Yield | 2.81% | 4.55% | -1.74 | OPCH | /fcf-yield <GO> |
| Operating Margin | 4.50% | 6.00% | -1.50 | OPCH | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 5.50% | 3.70% | +1.80 | HIMS | /net-margins <GO> |
| Revenue Growth (YoY) | 59.00% | 13.00% | +46.00 | HIMS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.95 | 3.81 | +0.14 | HIMS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | HIMS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.3 | 83.8 | -38.50 | OPCH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.10 | -0.05 | OPCH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 45.3x | 19.3x | +26.00 | OPCH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.46B | $4.77B | $1.69B | HIMS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HIMS REV | OPCH REV | HIMS GROSS % | OPCH GROSS % | HIMS FCF | OPCH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.35B | $5.65B | 73.8% | 19.3% | $194.4M | $217.1M |
| FY 2024 | $1.48B | $5.00B | 79.5% | 20.3% | $184.6M | $287.8M |
| FY 2023 | $872.0M | $4.30B | — | — | $34.2M | $177.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HIMS // BETA 1.05
OPCH // BETA 1.10